journal article·2025-09Open access

Glutathione/Cysteine Dual‐Consuming Prodrug Nanoassemblies for Potentiated Gas‐Photodynamic Therapy

Ning Tang, Fan Tong, Panchenghao Wu, Xiaofang Xie, Lulu Wang, Miao Yu, Xiaoyun Xing, Honglei Wang, Hao Wang, Huile Gao, Chuan Hu, Cheng Peng, Yang Zhou

Advanced Functional Materials· Volume 35· Issue 37

Abstract

Abstract Tuning the oxidative stress‐defense system plays a vital role in the treatment of breast tumors. In this study, a pyropheophorbide‐a (PPa)‐based prodrug nanoassembly is constructed by linking PPa with furoxan, a cysteine‐depleting nitric oxide (NO) donor, through a disulfide bond. The as‐prepared prodrug (NOSP) can assemble with distearoyl phosphoethanolamine‐PEG 2000 (DSPE‐PEG 2000 ) to form nanoassemblies in aqueous media. Following internalization by tumor cells, NOSP can respond to cysteine (Cys) and induce NO release to activate endogenous matrix metalloproteinases (MMP‐1, ‐2), leading to collagen degradation and improved drug delivery. In addition, Cys consumption can impede the biosynthesis of glutathione (GSH), while NOSP can react with high levels of intracellular GSH within seconds, thus synergizing photodynamic therapy against breast tumors and distant metastasis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Sulfur Compounds in Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Tropical Biological Resources of Ministry of Education School of Pharmaceutical Sciences Hainan University Haikou 570228 P. R. China

Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry West China School of Pharmacy Sichuan University Chengdu 610064 P. R. China

State Key Laboratory of Southwestern Chinese Medicine Resources Chengdu University of Traditional Chinese Medicine Chengdu Sichuan 611137 P. R. China

Department of Breast Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital & Institute Sichuan Cancer Center Affiliated Cancer Hospital of University of Electronic Science and Technology of China Chengdu 610041 P. R. China

References (28)

Show source-provided references
1. 10.1002/adma.20240272010.1002/adma.202402720 ↗
2. 10.1002/adfm.20240219410.1002/adfm.202402194 ↗
3. 10.1016/j.apsb.2023.11.00710.1016/j.apsb.2023.11.007 ↗
4. 10.1016/j.apsb.2023.11.01910.1016/j.apsb.2023.11.019 ↗
5. 10.1016/j.jconrel.2023.11.05810.1016/j.jconrel.2023.11.058 ↗
6. 10.1002/adfm.20240505110.1002/adfm.202405051 ↗
7. 10.1038/s41467-023-37315-010.1038/s41467-023-37315-0 ↗
8. 10.3389/fphar.2024.149539310.3389/fphar.2024.1495393 ↗
9. 10.1016/j.ccr.2024.21586310.1016/j.ccr.2024.215863 ↗
10. 10.1021/acsnano.2c1103710.1021/acsnano.2c11037 ↗
11. 10.1002/advs.20230920410.1002/advs.202309204 ↗
12. 10.1016/j.cclet.2022.05.03210.1016/j.cclet.2022.05.032 ↗
13. 10.1002/adhm.20220276910.1002/adhm.202202769 ↗
14. 10.1016/j.cclet.2022.10789110.1016/j.cclet.2022.107891 ↗
15. 10.1021/acs.nanolett.9b0109310.1021/acs.nanolett.9b01093 ↗
16. 10.1186/s40779-023-00454-y10.1186/s40779-023-00454-y ↗
17. 10.1002/adma.20230647610.1002/adma.202306476 ↗
18. 10.1021/acs.nanolett.8b0423610.1021/acs.nanolett.8b04236 ↗
19. 10.1002/adma.20211061410.1002/adma.202110614 ↗
20. 10.1021/acs.nanolett.2c0431210.1021/acs.nanolett.2c04312 ↗
21. 10.1021/jm960379t10.1021/jm960379t ↗
22. 10.1038/s41467-021-25159-510.1038/s41467-021-25159-5 ↗
23. 10.1002/adhm.20220308510.1002/adhm.202203085 ↗
24. 10.1021/acs.chemrev.0c0097710.1021/acs.chemrev.0c00977 ↗
25. 10.1021/acsnano.1c0049810.1021/acsnano.1c00498 ↗
26. 10.1002/advs.20230954210.1002/advs.202309542 ↗
27. 10.1021/acs.nanolett.4c0493810.1021/acs.nanolett.4c04938 ↗
28. 10.1021/acsnano.4c0639910.1021/acsnano.4c06399 ↗